Search Within

Li-Xuan Qin

Formats
  1. Journal Article (120)
  2. Meeting Abstract (72)
  3. Correspondence (1)
  4. Review (1)
Groups
  1. Biostatistics Service (194)
  2. Epidemiology and Biostatistics (194)
  3. Surgery (134)
  4. GSK Faculty (114)
  5. Tow Center for Developmental Oncology (TCDO) (109)
  6. Department of Pathology and Laboratory Medicine (94)

More Groups

People
  1. Samuel Singer (82)
  2. William Tap (60)
  3. Mark Dickson (58)
  4. Mary Keohan (55)
  5. Mrinal Gounder (53)
  6. Sandra D'Angelo (53)

More People

Years
  1. 2025 (8)
  2. 2024 (19)
  3. 2023 (11)
  4. 2022 (13)
  5. 2021 (5)
  6. 2020 (9)

More Years

Publications
  1. Journal of Clinical Oncology (51)
  2. Annals of Surgical Oncology (18)
  3. Clinical Cancer Research (14)
  4. Cancer Research (11)
  5. Annals of Surgery (8)
  6. Cancer Informatics (5)

More Publications

Publishers
  1. American Society of Clinical Oncology (57)
  2. American Association for Cancer Research (29)
  3. Springer (20)
  4. Elsevier Inc. (13)
  5. Oxford University Press (12)
  6. Lippincott Williams & Wilkins (11)

More Publishers

Results (194)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase I study of binimetinib (MEK162) combined with pexidartinib (PLX3397) in patients with advanced gastrointestinal stromal tumor
    Journal Article

    Rosenbaum, E.; Kelly, C.; D'Angelo, S. P.; Dickson, M. A.; Gounder, M.; Keohan, M. L.; Movva, S.; Condy, M.; Adamson, T.; Mcfadyen, C. R.; more...
    The Oncologist (2019)

    Fulltext@MSK | Save
  • A phase II trial of sorafenib and dacarbazine for leiomyosarcoma, synovial sarcoma, and malignant peripheral nerve sheath tumors
    Journal Article

    D'Adamo, D. R.; Dickson, M. A.; Keohan, M. L.; Carvajal, R. D.; Hensley, M. L.; Hirst, C. M.; Ezeoke, M. O.; Ahn, L.; Qin, L. X.; Antonescu, C. R.; more...
    The Oncologist (2019)

    Fulltext@MSK | Save
  • A phase Ib study of BGJ398, a pan-FGFR kinase inhibitor in combination with imatinib in patients with advanced gastrointestinal stromal tumor
    Journal Article

    Kelly, C. M.; Shoushtari, A. N.; Qin, L. X.; D’Angelo, S. P.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; Mcfadyen, C.; Sjoberg, A.; Singer, S.; more...
    Investigational New Drugs (2019)

    Fulltext@MSK | Save
  • Integrin α-10 gene expression is prognostic for metastasis and survival in myxofibrosarcoma and undifferentiated pleomorphic sarcoma
    Meeting Abstract

    Cass, R. W.; Okada, T.; Qin, L.; Socci, N.; Shen, Y.; Singer, S.
    Annals of Surgical Oncology (2019)

    Fulltext@MSK | Save
  • Yield of colonoscopy in identification of newly diagnosed desmoid-type fibromatosis with underlying familial adenomatous polyposis
    Journal Article

    van Houdt, W. J.; Wei, I. H.; Kuk, D.; Qin, L. X.; Jadeja, B.; Villano, A.; Hameed, M.; Singer, S.; Crago, A. M.
    Annals of Surgical Oncology (2019)

    Fulltext@MSK | Save
  • A phase II study of talimogene laherparepvec (T-VEC) and pembrolizumab in patients with metastatic sarcoma
    Meeting Abstract

    Kelly, C. M.; Bowler, T. G.; Munhoz, R. R.; Chi, P.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; Dholakia, R.; Condy, M. M.; Singer, S.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • PDLIM7 and CDH18 regulate the turnover of MDM2 during CDK4/6 inhibitor therapy-induced senescence
    Journal Article

    Klein, M. E.; Dickson, M. A.; Antonescu, C.; Qin, L. X.; Dooley, S. J.; Barlas, A.; Manova, K.; Schwartz, G. K.; Crago, A. M.; Singer, S.; more...
    Oncogene (2018)

    Fulltext@MSK | Save
  • A pair of datasets for microRNA expression profiling to examine the use of careful study design for assigning arrays to samples
    Journal Article

    Qin, L. X.; Huang, H. C.; Villafania, L.; Cavatore, M.; Olvera, N.; Levine, D. A.
    Scientific Data (2018)

    Fulltext@MSK | Save
  • Empirical evaluation of data normalization methods for molecular classification
    Journal Article

    Huang, H. C.; Qin, L. X.
    PeerJ (2018)

    Fulltext@MSK | Save
  • Senescence after growth arrest: A mechanism by which CDK4/6 inhibitors can mediate their activity suppressing tumor progression
    Meeting Abstract

    Koff, A.; Klein, M. E.; Dickson, M. A.; Antonescu, C.; Qin, L. X.; Dooley, S. J.; Schwartz, G.; Crago, A. M.; Singer, S.; Tap, W. D.
    Annals of Oncology (2018)

    Fulltext@MSK | Save